Glibenclamide as a neuroprotective antidementia drug

References

• Ashcroft, F., and Gribble, F., 2000. Tissue-specific effects of sulfonylureas: lessons from studies of cloned K(ATP) channels. Journal of diabetes and its complications, 14 (4), 192–196.
   PubMed Web of Science ®Google Scholar
• Avshalumov, M.V., and Rice, M.E., 2003. Activation of ATP-sensitive K+ (K(ATP)) channels by H2O2 underlies glutamate-dependent inhibition of striatal dopamine release. Proceedings of the national academy of sciences of the United States of America, 100 (20), 11729–11734.
   PubMed Web of Science ®Google Scholar
• Babenko, A.P., et al., 1998. A view of sur/KIR6.X, KATP channels. Annual review of physiology, 60, 667–687.
   PubMed Web of Science ®Google Scholar
• Bao, L., et al., 2005. Partial mitochondrial inhibition causes striatal dopamine release suppression and medium spiny neuron depolarization via H2O2 elevation, not ATP depletion. The journal of neuroscience, 25 (43), 10029–10040.
   PubMed Web of Science ®Google Scholar
• Caballero-Corchuelo, J., et al., 2019. Analysis of the characteristics of patients with diabetes mellitus who attend a tertiary hospital emergency department for a hypoglycemic event. Endocrinology, diabetes and nutrition, 66 (1), 19–25.
   PubMed Web of Science ®Google Scholar
• Dunn-Meynell, A.A., et al., 1998. Distribution and phenotype of neurons containing the ATP-sensitive K + channel in rat brain. Brain research, 814 (1–2), 41–54.
   PubMed Web of Science ®Google Scholar
• Emaeili, M.H., et al., 2018. ATP-sensitive potassium-channel inhibitor glibenclamide attenuates HPA axis hyperactivity, depression- and anxiety-related symptoms in a rat model of Alzheimer’s disease. Brain research bulletin, 137, 265–276.
   PubMed Web of Science ®Google Scholar
• Emaeili, M.H., et al., 2020. Glibenclamide mitigates cognitive impairment and hippocampal neuroinflammation in rats with type 2 diabetes and sporadic Alzheimer-like disease. Behavioural brain research, 379, 112359.
   PubMed Web of Science ®Google Scholar
• Groop, L.C., et al., 1991. Dose-dependent effects of glyburide on insulin secretion and glucose uptake in humans. Diabetes care, 14 (8), 724–727.
   PubMed Web of Science ®Google Scholar
• Heyer, E.J., et al., 2013. Inflammation and cognitive dysfunction in type 2 diabetic carotid endarterectomy patients. Diabetes care, 36 (10), 3283–3286.
   PubMed Web of Science ®Google Scholar
• Kempadoo, K.A., et al., 2016. Dopamine release from the locus coeruleus to the dorsal hippocampus promotes spatial learning and memory. Proceedings of the national academy of sciences of the United States of America, 113 (51), 14835–14840.
   PubMed Web of Science ®Google Scholar
• Kim, W.S., et al., 2010. Increased ATP-binding cassette transporter A1 expression in Alzheimer’s disease hippocampal neurons. Journal of Alzheimer’s disease, 21 (1), 193–205.
   PubMed Web of Science ®Google Scholar
• Koldamova, R., et al., 2014. ATP-binding cassette transporter A1: from metabolism to neurodegeneration. Neurobiology of disease, 72, 13–21.
   PubMed Web of Science ®Google Scholar
• Kurland, D.B., et al., 2016. The Sur1-Trpm4 channel regulates NOS2 transcription in TLR4-activated microglia. Journal of neuroinflammation, 13 (1), 130.
   PubMed Web of Science ®Google Scholar
• McNamara, C.G., and Dupret, D., 2017. Two sources of dopamine for the hippocampus. Trends in neurosciences, 40 (7), 383–384.
   PubMed Web of Science ®Google Scholar
• Ortega, F.J., et al., 2014. Blockade of microglial KATP -channel abrogates suppression of inflammatory-mediated inhibition of neural precursor cells. Glia, 62 (2), 247–258.
   PubMed Web of Science ®Google Scholar
• Patel, A.D., et al., 2010. Glibenclamide reduces hippocampal injury and preserves rapid spatial learning in a model of traumatic brain injury. Journal of neuropathology and experimental neurology, 69 (12), 1177–1190.
   PubMed Web of Science ®Google Scholar
• Patel, J.C., et al., 2011. Subsecond regulation of striatal dopamine release by pre-synaptic KATP channels. Journal of neurochemistry, 118 (5), 721–736.
   PubMed Web of Science ®Google Scholar
• Ren, Y., et al., 2016. CD200 inhibits inflammatory response by promoting KATP channel opening in microglia cells in Parkinson’s disease. Medical science monitor, 22, 1733–1741.
   PubMed Web of Science ®Google Scholar
• Sarookhani, M.R., et al., 2018. Involvement of adenosine triphosphate-sensitive potassium channels in the neuroprotective activity of hydrogen sulfide in the 6-hydroxydopamine-induced animal model of Parkinson’s disease. Behavioural pharmacology, 29 (4), 336–343.
   PubMed Web of Science ®Google Scholar
• Schain, M., and Kreisl, W.C., 2017. Neuroinflammation in neurodegenerative disorders – a review. Current neurology and neuroscience reports, 17 (3), 25.
   PubMed Web of Science ®Google Scholar
• Shi, X., et al., 2008. Kir6.2 knockout alters neurotransmitter release in mouse striatum: an in vivo microdialysis study. Neuroscience letters, 439 (3), 230–234.
   PubMed Web of Science ®Google Scholar
• Simard, J.M., et al., 2006. Newly expressed SUR1-regulated NC(Ca-ATP) channel mediates cerebral edema after ischemic stroke. Nature medicine, 12 (4), 433–440.
   PubMed Web of Science ®Google Scholar
• Simard, J.M., et al., 2012. Sulfonylurea receptor 1 in central nervous system injury: a focused review. Journal of cerebral blood flow and metabolism, 32 (9), 1171–1699.
   Web of Science ®Google Scholar
• Stokum, J.A., et al., 2017. Glibenclamide pretreatment protects against chronic memory dysfunction and glial activation in rat cranial blast traumatic brain injury. Behavioural brain research, 333, 43–53.
   PubMed Web of Science ®Google Scholar
• Tosun, C., et al., 2013. Inhibition of the Sur1-Trpm4 channel reduces neuroinflammation and cognitive impairment in subarachnoid hemorrhage. Stroke, 44 (12), 3522–3528.
   PubMed Web of Science ®Google Scholar
• van Deijk, A.F., et al., 2017. Astrocyte lipid metabolism is critical for synapse development and function in vivo. Glia, 65 (4), 670–682.
   PubMed Web of Science ®Google Scholar
• Xu, F., et al., 2019. Glibenclamide ameliorates the disrupted blood-brain barrier in experimental intracerebral hemorrhage by inhibiting the activation of NLRP3 inflammasome. Brain and behavior, 9 (4), e01254.
   PubMed Web of Science ®Google Scholar
• Xu, Z., et al., 2017. Glibenclamide attenuates blood-brain barrier disruption in adult mice after traumatic brain injury. Journal of neurotrauma, 34 (4), 925–933.
   PubMed Web of Science ®Google Scholar
• Zha, X., et al., 2001. Endocytosis is enhanced in tangier fibroblasts: possible role of atp-binding cassette protein A1 in endosomal vesicular transport. The journal of biological chemistry, 276 (42), 39476–39483.
   PubMed Web of Science ®Google Scholar